Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its structure supports high enantioselectivity, making it valuable in asymmetric synthesis for active pharmaceutical ingredients (APIs). Commonly employed in the preparation of serotonin and dopamine receptor modulators due to the favorable electronic and steric properties imparted by the trifluoromethyl and bromo substituents. Also utilized in agrochemicals for the creation of bioactive molecules with improved metabolic stability.